{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:41:06Z","timestamp":1791423666772,"version":"4.3.3"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ghir.2026.101705","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:52:47Z","timestamp":1779231167000},"page":"101705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Is Somatrogon different? 6-month clinical outcomes and follow-up data in Turkish children transitioned from Somatropin to Somatrogon"],"prefix":"10.1016","volume":"84","author":[{"given":"Nurgul","family":"Atas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia Deniz","family":"K\u0131l\u00e7\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fato\u015f \u00c7irkin","family":"Melik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Karao\u011flan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Keskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serpil","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ghir.2026.101705_bb0005","doi-asserted-by":"crossref","first-page":"e2717","DOI":"10.1210\/clinem\/dgac220","article-title":"Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study","volume":"107","author":"Deal","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2026.101705_bb0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000523791","article-title":"Long-acting growth hormone preparations and their use in children with growth hormone deficiency","volume":"96","author":"Pampanini","year":"2023","journal-title":"Horm. Res. Paediatr."},{"issue":"6","key":"10.1016\/j.ghir.2026.101705_bb0015","doi-asserted-by":"crossref","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","article-title":"Long-acting growth hormone preparations\u2013current status and future considerations","volume":"105","author":"Miller","year":"2020","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.ghir.2026.101705_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016223","article-title":"Non-compliance with growth hormone treatment in children is common and impairs linear growth","volume":"6","author":"Cutfield","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ghir.2026.101705_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ghir.2016.04.006","article-title":"Early cessation and non-response are important and possibly related problems in growth hormone therapy: an OZGROW analysis","volume":"29","author":"Hughes","year":"2016","journal-title":"Growth Horm. IGF Res."},{"issue":"4","key":"10.1016\/j.ghir.2026.101705_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4274\/jcrpe.galenos.2019.2019.0088","article-title":"Achieving optimal short-and long-term responses to paediatric growth hormone therapy","volume":"11","author":"Wit","year":"2019","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101705_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2018.10.004","article-title":"Long-term adherence to growth hormone therapy in a large health maintenance organization cohort","volume":"44","author":"Farfel","year":"2019","journal-title":"Growth Horm. IGF Res."},{"issue":"8","key":"10.1016\/j.ghir.2026.101705_bb0040","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1530\/EC-18-0172","article-title":"Adherence and long-term growth outcomes: results from the easypod\u2122 connect observational study (ECOS) in paediatric patients with growth disorders","volume":"7","author":"Koledova","year":"2018","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.ghir.2026.101705_bb0045","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40271-017-0237-9","article-title":"Understanding treatment burden for children treated for growth hormone deficiency","volume":"10","author":"Brod","year":"2017","journal-title":"The Patient-Patient-Centered Outcomes Research."},{"issue":"5","key":"10.1016\/j.ghir.2026.101705_bb0050","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/clinem\/dgab928","article-title":"Effective GH replacement with once-weekly somapacitan vs daily GH in children with GHD: 3-year results from REAL 3","volume":"107","author":"S\u00e4vendahl","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ghir.2026.101705_bb0055","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1210\/clinem\/dgab529","article-title":"Weekly lonapegsomatropin in treatment\u2013na\u00efve children with growth hormone deficiency: the phase 3 heiGHt trial","volume":"106","author":"Thornton","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101705_bb0060","series-title":"Pediatric Endocrinology","article-title":"Growth and growth disorders","author":"Lifshitz","year":"2004"},{"issue":"2","key":"10.1016\/j.ghir.2026.101705_bb0065","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4274\/jcrpe.galenos.2019.2019.0127","article-title":"New features for child metrics: further growth references and blood pressure calculations","volume":"12","author":"Demir","year":"2020","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2026.101705_bb0070","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2013-3059","article-title":"Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations","volume":"99","author":"Bidlingmaier","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:12:32Z","timestamp":1780953152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637426000274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":14,"alternative-id":["S1096637426000274"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101705","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Somatrogon different? 6-month clinical outcomes and follow-up data in Turkish children transitioned from Somatropin to Somatrogon","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101705"}}